These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)]. Fourrier A; Mouton Y Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283 [No Abstract] [Full Text] [Related]
3. [Treatment of hyperlipidemias. Value of a new hypolipidemic drug clofibride, (M-G. 46)]. Leutenegger M; Choisy H; Caron J; Paris H Therapie; 1974; 29(4):599-610. PubMed ID: 4439371 [No Abstract] [Full Text] [Related]
4. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate]. Barisone D; Gallo G; Accardo S Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766 [No Abstract] [Full Text] [Related]
5. [Interference of clofibrate in metabolic compensation in dyslipidemic diabetics]. Gatti A; Carletta C Clin Ter; 1979 Oct; 91(1):57-65. PubMed ID: 397871 [No Abstract] [Full Text] [Related]
6. [Comparative evaluation of beta-benzalbutyramide and clofibrate in the short-term treatment of hyperlipidemic patients]. Marini U; Bargiggia A; Riboli P Farmaco Prat; 1981 Dec; 36(12):532-41. PubMed ID: 7319020 [No Abstract] [Full Text] [Related]
7. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia]. Warembourg H; Jaillard J Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605 [No Abstract] [Full Text] [Related]
8. Diet and drugs in the treatment of hyperlipidemias. Med Lett Drugs Ther; 1970 May; 12(10):42-4. PubMed ID: 5514225 [No Abstract] [Full Text] [Related]
9. [Hypolipemic effectiveness of using miskleron in diabetes mellitus in children and adolescents with lipodystrophies]. Belousova LV Pediatriia; 1980 Jun; (6):39-41. PubMed ID: 7402836 [No Abstract] [Full Text] [Related]
10. [Clinical experimentation of clofibride. Apropos of 40 cases]. Warembourg H; Jaillard J Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928 [No Abstract] [Full Text] [Related]
11. [Clinical experimentation with RU 19,(83 (Dabical) calcium clofibrate]. Pauchant M; Bourbillon JP Lille Med; 1976 Jan; 21(1 suppl 1):24-8. PubMed ID: 1256229 [No Abstract] [Full Text] [Related]
12. [Hypolipidemic efficacy of clofibrate preparations (atromid C, atromidine, mixleron) in coronary atherosclerosis with different types of hyperlipoproteinemia]. Zakharov VN Ter Arkh; 1977; 49(4):111-3. PubMed ID: 867253 [No Abstract] [Full Text] [Related]
13. High death rate from neoplasms in French diabetic and non-diabetic men. Balkau B; Charles MA; Eschwège E Lancet; 1998 May; 351(9114):1512. PubMed ID: 9605828 [No Abstract] [Full Text] [Related]
14. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related]